131 results
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
26 Apr 24
Avenue Therapeutics Announces Reverse Stock Split
4:39pm
approval, they will remain subject to substantial regulatory scrutiny; the effects of current and future laws and regulations relating to fraud
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
18 Mar 24
Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights
4:10pm
, they will remain subject to substantial regulatory scrutiny; the effects of current and future laws and regulations relating to fraud and abuse, false claims
424B3
8f19 7yw9vea3
2 Feb 24
Prospectus supplement
12:00am
8-K
EX-10.2
j4l7ot 4l
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
424B4
dg7ef n11
2 Nov 23
Prospectus supplement with pricing info
9:00am
FWP
gc20s1yntoqf7
5 Oct 23
Free writing prospectus
5:05pm
FWP
s5do zxddleki
3 Oct 23
Free writing prospectus
5:47pm